SEC CIK 1709050

Froimson Mark

Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.

Current Positions

CompanyShares OwnedAs Of
PCRXview stock →26,5412026-06-10

Position History — PCRX

Reported shares owned immediately after each Form 4 transaction, over time.

08,84717,69426,5412017-082019-062020-062021-062022-052023-062024-082026-032026-06

Recent Filings — PCRX

DateActivitySharesPriceOwned After
2026-06-10Grant / award (derivative)10,891$0.0010,891
2026-06-10Grant / award6,405$0.0026,541
2026-03-17Open-market sale500$21.8120,136
2025-06-11Grant / award (derivative)11,279$0.0011,279
2025-06-11Grant / award6,163$0.0020,636
2024-08-12Open-market buy1,400$11.5814,473
2024-06-12Grant / award (derivative)12,179$0.0012,179
2024-06-12Grant / award5,230$0.0013,073
2023-06-14Grant / award (derivative)12,925$0.0012,925
2023-06-14Grant / award1,775$0.007,843
2022-06-08Grant / award (derivative)8,225$0.008,225
2022-06-08Grant / award1,160$0.006,068
2022-05-09Open-market sale1,000$59.374,908
2021-12-17Gift400$0.005,908
2021-06-09Grant / award (derivative)7,626$0.007,626
2021-06-09Grant / award1,066$0.006,308
2021-03-15Open-market sale734$72.265,242
2020-06-09Grant / award (derivative)8,027$0.008,027
2020-06-09Grant / award1,260$0.005,976
2019-12-16Gift300$0.004,716
2019-06-05Grant / award (derivative)8,437$0.008,437
2019-06-05Grant / award4,134$0.005,016
2018-06-13Grant / award (derivative)4,693$0.004,693
2018-06-13Grant / award782$0.00882
2017-08-08Open-market buy100$37.13100
2017-06-14Grant / award (derivative)8,144$0.008,144

Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.